Now on sale to the public for well over a year
It does help obese people lose weight
It is not a mass population "diet" drug intended for people to lose 20 pounds
Competition drugs on the market are mixtures of old compounds and have many health issues
Rx numbers for Belviq were low initially, but are steadily increasing every month
The longer Belviq is on the market with successful use, the more likely the EU and other countries will eventually approve for use. Candada and Mexico could happen soon
New improved compound being tested now
ARNA is expanding the use of Belviq to smoking cessation and other addictive behaviors
ARNA has other compounds in the pipeline that are looking very promising
Eisai has expanded the sales force and TV advertising has moved to prime time
Current share price of ARNA is a huge BUY POINT
Sentiment: Strong Buy
That is just one more to put on the ignore list immediatly
ARNA didn't take the usual route of small pharma and borrow $500 million+ from Wall St. bankers and do its own marketing and launch. Instead they made a marketing deal with Eisai. Imagine how much money Wall St. bankers lost out on making with that action? Add the fact that Belviq is not a "diet" pill which can be marketed to the masses. It is for treatment of obesity which has a smaller market and it is taking time to build up Rx numbers.
There was down time in the second quarter for some boiler and gassifier issues. Don't think another major downtime for plant "turn around" is planned for at least a year.
Probably not huge, but most likely continuing to increase. Current share price is a buying opportunity.
No one likes the blatant bashing that has no basis. However anyone who takes cues from Yahoo message boards on whether to purchase shares of a stock is destined to have trouble.
The weekly Rx numbers are growing - slower than we would like, but eventually it will hit the tipping point and really take off. Belviq works, new global markets on the horizon, anti-cessation indication for Belviq, Bel-Phen combo in the pipeline along with other new compounds. Buy now, stay long!
Sentiment: Strong Buy
Informed longs knew that when it happened. The only people who tried to make something of it were those with short positions. Uninformed longs sold - very foolish of them.
Share price isn't going to $10 next week, but over time ARNA will succeed. Steady growth in Rx numbers, new drugs in pipeline, new global markets opening soon. If you are long ARNA just be patient. If you are short ARNA, well you better cover ASAP.
The key for ARNA is growth in Rx numbers for Belviq and the pipeline it has in development. Small cap pharma doesn't have the resources to do share buybacks.
He didn't pick the week or day to sell. By the way he still owns 2 million shares. If you live in San Diego as I do and have worked in R&D there are many reasons for Jack selling some shares. Maybe he wanted to buy a nice home in LaJolla, buy a nice new yacht and join San Diego Yacht club, join LaJolla tennis club, etc, etc. etc.
Meanwhile many retail holders panicked because of J. Leif selling of shares (not in his control) and proceeded to sell. Share price has fallen and short position holders have loved it! Belviq Rx numbers once again on the increase with positive future prospects. I just bought more the past few days at $4.xx
Good obesity drug, good prospects for new global markets, good pipeline, good investment! That is all you need to know.
My of my. Well I am long ARNA that is true. Every post I have ever made concerning my views on ARNA have always had rationale to support the views. Most of the bashing posts never have that or are straight out lies.
They are not being altruistic and trying to warn anyone about a possible bad trade or investment. They all have short positions and are trying desperately to get the share price lower so they can exit their short position.
Yes, I listened to it as well. The poster here yesterday claiming that Craig had mentioned a NOD from Canada was full of BS.